U.S. Aerospace & Defense Stock News

NYSE:BAX
NYSE:BAXMedical Equipment

Is Baxter International (BAX) A Bargain On Its CFO Change And Turnaround Moves?

Why Baxter International’s CFO transition matters for investors Baxter International (BAX) is reshaping its senior finance team during a multiyear restructuring, appointing John Rogers as Chief Financial Officer and Executive Vice President from October 1, 2026, with interim arrangements starting in mid September. These leadership moves arrive alongside changes to Baxter International’s credit agreement and a US$600 million debt tender offer. Together, they put capital structure, leverage...
NYSE:SHW
NYSE:SHWChemicals

Why Everyone Is Watching Sherwin Williams (SHW) Right Now

Krylon, a Sherwin-Williams (SHW) brand, has introduced Krylon Harmony, a water-based spray paint designed to reduce odor, flammability concerns and overspray, and to support indoor and year-round DIY projects. See our latest analysis for Sherwin-Williams. The new Krylon Harmony launch comes as Sherwin-Williams’ share price trades at US$346.59, with a 30-day share price return of 8.34% and a 90-day share price return of 12.14%. The 3-year total shareholder return of 34.50% contrasts with a...
NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global (SPGI), What Is Behind The Fresh Attention?

S&P Global (SPGI) is drawing attention after announcing an expanded collaboration with Microsoft to bring its AI ready data and analytics directly into Microsoft 365 Copilot workflows. See our latest analysis for S&P Global. Recent price moves show some short term support for S&P Global, with a 7 day share price return of 2.98% and a 90 day gain of 3.28%. However, the share price is down 15.87% year to date and the 1 year total shareholder return has declined 17.40%, while the 3 year total...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Why Did Opera (OPRA) Shares Move Today?

Opera (NasdaqGS:OPRA) is back in focus after its second quarter 2026 earnings, where revenue and net income for both the quarter and first half materially outpaced the prior year and management raised full year guidance. See our latest analysis for Opera. Despite the strong Q2 report and raised guidance, Opera’s recent share price performance has been mixed. The 7 day share price return declined 6.74% and the 30 day share price return declined 1.40%. In contrast, the year to date share price...
NasdaqGM:HPK
NasdaqGM:HPKOil and Gas

HighPeak Energy (HPK) Stock Could Still Be A Bargain After An 86% Run

HighPeak Energy has delivered an 86.1% gain year to date, which raises a clear question for investors about whether the current share price still reflects good value given the broader valuation checks and recent business momentum. Year to date, HighPeak Energy is up 86.1%, which puts recent buyers on strong gains and sets a higher bar for any further upside to be justified. Recent revenue and margin progress can support confidence in the earnings base. At the same time, the share price now...
NYSE:SLB
NYSE:SLBEnergy Services

How Investors Are Reacting To SLB (SLB) Winning Brunei Shell’s First Fully Integrated Restoration Deal

SLB announced in August 2026 that it had been awarded a contract by Brunei Shell Petroleum to deliver an integrated production restoration solution for shut-in wells across multiple offshore fields, covering subsurface evaluation, well selection, engineering, execution, monitoring and logistics under a single coordinated model. This marks Brunei Shell Petroleum’s first use of a fully integrated production restoration approach, highlighting how mature offshore assets are increasingly being...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

Can Grand Canyon Education (LOPE) Stay Below Fair Value After A 66% Five Year Gain?

Grand Canyon Education stock has delivered a 66.1% gain over the past five years, yet its current checks point to a mixed valuation picture rather than a clear bargain or an obviously expensive price. The 66.1% return over five years shows that long term holders have been rewarded, which puts more focus on whether the current price at US$147.46 still offers an appealing entry point. Expectations around Grand Canyon Education's ability to keep converting its education services into steady...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

What Does Nebius Group (NBIS) Signal With Its $5 Billion AI Funding Move?

Nebius Group (NasdaqGS: NBIS) has priced an upsized US$5b convertible note offering to finance accelerated AI and data center expansion. The company has also completed a large secondary share exchange that increases the potential conversion of debt into equity. The combined moves reshape Nebius Group's capital structure and raise fresh questions about dilution and execution risk for shareholders. For more ideas in AI infrastructure that relate closely to what Nebius Group is doing with this...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland-Cliffs (CLF) Is Down 5.3% After DOE-Backed $500 Million Middletown Modernization Deal - Has The Bull Case Changed?

Cleveland-Cliffs recently announced a US$1.00 billion modernization program for its Middletown Works steel plant in Ohio, with US$500.00 million in cost-sharing support from the U.S. Department of Energy to upgrade blast furnace operations, material handling, AI-based process controls, and energy efficiency while maintaining production and jobs. Beyond the headline investment size, the DOE-backed plan signals federal support for keeping Cleveland-Cliffs’ automotive-focused, domestically...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

How New NASA, Multi-Satellite Deals and Record Backlog Will Impact Intuitive Machines (LUNR) Investors

Intuitive Machines, Inc. recently announced multiple contract wins, including a NASA JPL selection for the EAGLE-VSWIR Earth observation mission flying on its IM 300 spacecraft and an authorization to proceed on a multi-satellite communications infrastructure program with an anticipated value of more than US$600 million, alongside reporting Q2 2026 revenue of US$206.17 million and a net loss of US$46.45 million. Together with a reported record backlog of about US$1.8 billion and reaffirmed...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

The Bull Case For Addus HomeCare (ADUS) Could Change Following COO Leadership Shift - Learn Why

Addus HomeCare Corporation recently announced that President and Chief Operating Officer Heather Dixon has left the company, with former President and COO Brad Bickham returning as interim Chief Operating Officer for one year, effective immediately. Bickham’s prior involvement in building Addus’s personal care, hospice, and home health platforms, as well as its acquisition program, gives investors a familiar operational leader during this management transition. We’ll now examine how...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Why Reddit (RDDT) Is Down 13.9% After Joining the S&P 500 And Exiting Russell Small-Cap

Earlier this month, S&P Dow Jones Indices added Reddit, Inc. (NYSE:RDDT) to the S&P 500 and several related large-cap and sector indices, while it exited a Russell small-cap growth benchmark and announced an upcoming change in its Chief Legal Officer. This reshuffling into major S&P indices marks Reddit’s transition into the large-cap mainstream, amplifying its visibility among benchmark-focused institutional investors and index-tracking funds. Next, we’ll examine how Reddit’s move into the...
NYSE:ARW
NYSE:ARWElectronic

Arrow’s Expanded IBM Reach in Europe Might Change The Case For Investing In Arrow Electronics (ARW)

Arrow Electronics recently expanded its IBM distribution coverage to seven additional European countries, enabling it to supply IBM infrastructure, automation and data solutions to channel partners in Bulgaria, Croatia, the Czech Republic, Germany, Slovakia, Slovenia and Ukraine. This move builds on Arrow’s long-running global collaboration with IBM and broadens access to its experience centers, local technical support and IBM Practice accelerator program for partners across these...
NYSE:STZ
NYSE:STZBeverage

Molson Coors Stock And 2 US Exporters Exposed To Canada Tariff Talks

Tariff threats rarely hit consumers and companies evenly, and the current Canada US trade talks are a clear example. As Washington weighs fresh duties and partial rollbacks, some cross border food and beverage exporters with real Canadian revenue exposure could see meaningful shifts in demand and pricing power. This article walks through three such U.S. stocks exposed to the news, and why their trade footprint might matter for your portfolio. The three U.S. stocks discussed below are just a...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

ePlus (PLUS) Stock Looks Above Fair Value At Current Levels

After a 62.9% total return over the past five years, ePlus stock is no longer an obvious bargain at first glance, and a fresh look at its valuation shows mixed signals. The intrinsic value estimate from a Discounted Cash Flow (DCF) model points to a premium price tag, while traditional market multiples indicate the current level looks roughly in line with peers. ePlus has returned 62.9% over five years, which sets a higher bar for any new upside from today’s valuation. Future revenue and...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Stock Still Looks Below Fair Value As CFO Change Nears

After a 121.1% return over the past year, Centene's share price has moved sharply higher, while its valuation checks still suggest the stock leans cheap rather than expensive. Centene has delivered a 121.1% return over the last 12 months, which puts extra focus on whether the recent share price strength is already pricing in key expectations. The planned CFO handover to Chris Neczypor after Drew Asher retires may support confidence in financial stewardship, although any bumps in the...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

Did JFrog's (FROG) AI‑Security swampUP 2026 Agenda Just Reframe Its Investment Narrative?

In August 2026, JFrog announced the all-star speaker lineup for its swampUP 2026 user conference in New York City, bringing together leaders from Anthropic, Microsoft, NVIDIA, AT&T, and others to address software supply chain security and AI-era development risks. The event’s focus on securing AI models, governing agentic tools, and closing the gap between perceived and actual software supply chain security underscores how central JFrog aims to be in managing trusted software delivery as...
NasdaqCM:DVLT
NasdaqCM:DVLTSemiconductor

Datavault AI (DVLT) Reports Higher Revenue And Wider Losses, Is The Valuation Still Compelling?

Datavault AI (DVLT) is back in focus after its second quarter 2026 report on 19 August, which showed higher revenue along with a much larger net loss, delayed SEC filings, and fresh securities class action allegations. See our latest analysis for Datavault AI. At a share price of US$0.3186, Datavault AI has seen its year to date share price return fall 68.46%, while the 1 year total shareholder return is down 23.69% and the 5 year total shareholder return has declined 99.90%. This suggests...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

What Does Qualcomm (QCOM) Gain From Sergio Buniac Leading Its AI Device Push?

Qualcomm (NasdaqGS: QCOM) has appointed former Motorola Devices President Sergio Buniac to lead its Mobile, Compute and Personal AI segment. The expanded unit covers Qualcomm’s smartphone, personal computing, wearables and AI device businesses. Buniac brings global experience in device strategy and operations into this broadened leadership role. The move aligns with Qualcomm’s effort to grow its presence in next generation AI devices and other adjacent markets. For readers looking beyond...
NasdaqGS:WDC
NasdaqGS:WDCTech

Is Western Digital (WDC) Cheap On AI Storage Demand Or Are Risks Already Priced In?

Western Digital (WDC) is back in focus as investors reassess AI related storage demand, sector tailwinds, and perceived undervaluation following a strong multi year run that now faces growing macro headwinds. See our latest analysis for Western Digital. Western Digital's share price has pulled back recently, with a 1 day share price return of a 2.05% decline and a 30 day share price return of a 17.47% decline, even though the year to date share price return is 144.77% and the 3 year total...
NYSE:ANDG
NYSE:ANDGProfessional Services

Andersen Group (ANDG) Completed A $188.5 Million Follow On Equity Offering

Andersen Group (NYSE:ANDG) has completed a significant follow-on equity offering, marking a material change to its capital structure. The new equity capital is intended to support the company's plans around funding initiatives, managing existing obligations, or pursuing potential acquisitions. The offering follows increased attention on how Andersen Group plans to finance its next phase of business development. This kind of capital raise highlights a broader set of under-the-radar companies...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Can Gilead Sciences (GILD) Justify Its Valuation On The Nucleai Oncology AI Deal?

Nucleai’s new collaboration with Gilead Sciences (GILD) centers on AI driven analysis of tissue samples to support antibody drug conjugate programs across several oncology indications. For investors, the focus is how this might influence Gilead’s oncology strategy and perceived pipeline strength. See our latest analysis for Gilead Sciences. Gilead Sciences’ recent collaboration news lands as the share price trades at US$146.12, with a 30 day share price return of 12.11% and a 1 year total...
NYSE:JBL
NYSE:JBLElectronic

3 AI Infrastructure Stocks Turning Data Center Demand Into Cash Flow

Global bond yields remain elevated, and US 10 year and 30 year yields have rebounded, which keeps funding costs in focus for any capital heavy project. AI infrastructure stocks sit right in that reality because they need significant spending on data centers, power and cooling. This article walks through the AI Infrastructure Stocks screener and highlights three stocks that illustrate how this theme is turning into tangible cash flow. The stocks in the article below are just a starting sample,...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Why Kura Oncology (KURA) Is Up 9.5% After New Menin Inhibitor Data And Q2 Results

In August 2026, Kura Oncology reported second-quarter revenue of US$20.87 million and a net loss of US$68.33 million, while also highlighting six-month revenue of US$39.14 million and a net loss of US$141.66 million for the period ended June 30, 2026. A new Blood journal publication detailed the discovery and preclinical development of Kura’s FDA-approved menin inhibitor ziftomenib (KOMZIFTI), underscoring its differentiated activity across leukemia models and its retained activity against...